Clinical Trial Update: A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX) [Phase 2]

View source ↗

Summary

This clinical trial update reports on the Phase 2 study of EDG-5506 for Duchenne Muscular Dystrophy in children. The trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• EDG-5506 (EDG-5506)

Snippet

Sponsor: Edgewise Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING